Mr. Kato has more than 30 years’ experience working at large multi-national pharmaceutical companies, including Roche and Amgen.

regulatory science for the development of global product development strategies. Mr. Kato achieved several successful globally-integrated programs involving Japan by leading global project teams through PMDA consultations and clarifying the regulatory requirements for Japanese submissions—including CTNs and Japanese NDAs—for global product development programs.